Coronavirus (COVID-19) Patient/Carer Notice



Prof Sutton and team win funding for BioPen


Prof Sutton and research team showcasing the iFix BioPen

Professor Gerard Sutton and his team of researchers from the University of Sydney and University of Wollongong won a prestigious $1.1M research grant from the NSW Medical Device Fund for their corneal BioPen.

The Medical Device Fund chooses medical technology ideas that they believe have the potential to revolutionise healthcare.

The iFix – a 3D-printing pen and bioink that seals eye wounds to treat corneal injuries – releases the bioink directly onto the eye to help corneal cells grow and prevent infection by creating a barrier. This allows corneal ulceration to heal faster and reduces long-term damage.

Corneal ulceration is a major cause of blindness in developing countries and around 55,000 people are hospitalised each year in Australia with corneal injuries.

The funding will help move this great concept from the lab to the clinic, helping many thousands of patients here and overseas. The iFix is currently in the testing phase and the team anticipates human trials commencing in 2019.

Read the University of Sydney’s announcement about the award.

Professor Gerard Sutton is an internationally recognised expert in corneal conditions, cataract surgery and laser eye surgery. In addition to his ophthalmic practice, Professor Sutton is a researcher and lecturer at the University of Sydney. He practises at Vision Eye Institute Chatswood.

Sampling the iFix BioPeniFix BioPen

Research team from the University of Sydney and University of WollongongResearch grant awarded for iFix BioPen

Have a question?

IMPORTANT: If you are concerned about your eyes and require an urgent consultation, DO NOT use this form. Please call one of our clinics during office hours or contact your nearest emergency department.

coloured spectrum bar